Biotechnology
New patent expiration for Viiv Hlthcare drug SELZENTRY – DrugPatentWatch
Copyright © DrugPatentWatch. Originally published in Recently expired patent for the drug Viiv Hlthcare SELZENTRY
Annual Drug Patent Expiration for SELZENTRY
Selzentry is a drug marketed by Viiv Healthcare and is included in two NDAs. It is available from two suppliers. There are two patents protecting this drug and one Paragraph IV challenge.
SELZENTRY drug price trends.
The generic ingredient in SELZENTRY is maraviroc. Two registered suppliers for this compound. Additional details are available on the maraviroc profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
Make Better Decisions with DrugPatentWatch
» Start Your Free Trial Today «
Copyright © DrugPatentWatch. Originally published in Recently expired patent for the drug Viiv Hlthcare SELZENTRY
